SHIONONE
SHIONONE Basic information
- Product Name:
- SHIONONE
- Synonyms:
-
- SHIONONE
- 2(1H)-Chrysenone,hexadecahydro-1,4b,6a,8,10a,12a-
- hexamethyl-8-(4-methyl-3-pentenyl)-,(1R,4aS,4bS,6aS,8R,10aR,10bS,12aS)-
- 18,19-Seco-D:A-friedolup-19-en-3-one
- 3β,5,8,17aβ-Tetramethyl-3-(4-methyl-3-pentenyl)-D-homo-5α-androstan-17-one
- Shionone ,98%
- 21-Shionen-3-one
- Shionone, 98%, from Aster tataricus L. f.
- CAS:
- 10376-48-4
- MF:
- C30H50O
- MW:
- 426.72
- Product Categories:
-
- chemical reagent
- pharmaceutical intermediate
- phytochemical
- reference standards from Chinese medicinal herbs (TCM).
- standardized herbal extract
- Mol File:
- 10376-48-4.mol
SHIONONE Chemical Properties
- Melting point:
- 161-162°
- alpha
- D26.5 -56.1° (c = 1.07 in chloroform)
- Boiling point:
- 485.6±14.0 °C(Predicted)
- Density
- 0.941±0.06 g/cm3(Predicted)
- solubility
- Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
- form
- Powder
- color
- White to off-white
- optical activity
- -56.126.5 (c 1.07, CHCl3)
- LogP
- 10.401 (est)
Safety Information
- Safety Statements
- 24/25
- HS Code
- 29143990
SHIONONE Usage And Synthesis
Uses
Shionone is an effective inhibitor of human neutrophil elastase which may be used as a treatment for inflammatory lung diseases including H1N1 and SARS virus infections.
Chemical Properties
White crystalline powder, soluble in organic solvents such as methanol, ethanol, and DMSO, derived from Aster tataricus.
Uses
Shionone is an effective inhibitor of human neutrophil elastase which may be used as a treatment for inflammatory lung diseases including H1N1 and SARS virus infections.
Definition
ChEBI: A tetracyclic triterpenoid that is perhydrochrysene which is substituted by methyl groups at positions 1, 4bbeta, 6aalpha, 8beta, 10abeta and 12a positions, by a 4-methylpent-3-enyl group t the 8alpha position, and with an oxo group at position 2.
in vivo
Shionone (orally administration; 80 mg/kg; 3 days; once daily) shows the trend of enhancing sputum secreting, but has no effect on ammonia-induced cough and reduces xylene-induced ear edema[1].
| Animal Model: | ICR male mice[1] |
| Dosage: | 80 mg/kg |
| Administration: | Orally administration; 3 days; once daily |
| Result: | Reduced the ear edema for 11.3% by use shionone. |
target
ERK | IkB | NOS | IKK
SHIONONESupplier
- Tel
- +86-21-20908456
- sales@BioChemBest.com
- Tel
- 0757-86329057 18934348241
- sales4.gd@hwrkchemical.com
- Tel
- 400-6009262 16621234537
- chenyj@titansci.com
- Tel
- 0871-65217109 13211707573;
- y.liu@mail.biobiopha.com
- Tel
- 4008-755-333 18080918076
- 800078821@qq.com
SHIONONE(10376-48-4)Related Product Information
- PURPURIN
- FRIEDELAN-3BETA-OL
- 5,7-Dihydrox -4'-methoxyisoflavone
- ASTRAGALIN
- roburic acid
- Madecassoside
- Pachymic acid
- Terrestrosin D
- Carboxyatractyloside
- Terrestrosin K
- dipotassium dihydrogen 15alpha-hydroxy-2beta-[[2-O-isovaleryl-3,4-di-O-sulphonato-beta-D-glucopyranosyl]oxy]kaur-16-ene-18,19-dioate
- Madecassic acid
- taxusin
- Perillartine
- (-)-PERILLALDEHYDE
- Jaceosidin
- Paclitaxel
- Pterostilbene